Discover 431 paid clinical trials in Colorado Springs, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Location: Englewood CO, Farmington NM, Wichita KS, Lincoln NE,
Sponsor: Paradigm Health
Sex: All
Age: 18+
Code: NCT06605404
Recruiting
First In Human Study of CX-801 in Advanced Solid Tumors
for
Solid Tumor, Adult
Location: Englewood CO, Fort Worth TX, Los Angeles CA,
Sponsor: CytomX Therapeutics
Sex: All
Age: 18+
Code: NCT06462794
Phase 1, Recruiting
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: Englewood CO, Aurora CO, Salt Lake City UT, Murray UT,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase 3, Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
for
Melanoma (Skin Cancer),
Location: Englewood CO, West Valley City UT, Fairway KS,
Sponsor: Aminex Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07287917
Phase 1, Phase 2, Recruiting
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor,
Location: Denver CO, Tucson AZ, Cleveland OH, Washington D.C. DC,
Sponsor: Vaxiion Therapeutics
Sex: All
Age: 18+
Code: NCT05901285
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
for
Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
Location: Englewood CO, Albuquerque NM, Wichita KS, Scottsdale AZ,
Sponsor: Lighthouse Pharmaceuticals, Inc.
Sex: All
Age: 55 - 70+
Code: NCT06847321
Phase 2, Recruiting
A Study of Buntanetap in Participants With PD
for
Parkinson's Disease (PD), Deep Brain Stimulation
Location: Englewood CO, Tulsa OK, Kansas City KS, Sun City AZ,
Sponsor: Annovis Bio Inc.
Sex: All
Age: 40 - 70+
Code: NCT07284784
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy